AKT1 and fatty liver disease: Subsequent mechanistic investigation revealed that lycorine alleviated hepatic steatosis, oxidative stress, and ferroptosis through suppression of phosphorylated epidermal growth factor receptor (EGFR) expression, leading to inhibition of the PI3K/AKT signaling pathway.